Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A second inhalation rapid human insulin has been approved by the FDA. The first inhaled insulin (Exubera) was approved in 2006 and was withdrawn from the market by Pfizer due to low acceptance and poor sales after about 13 months on the market

Human Insulin Inhalation Powder (Afrezza®)